000			02002 a2200589 4500
005			20250517150103.0
264		0	_c20181023
008			201810s 0 0 eng d
022			_a1440-1797
024	7		_a10.1111/nep.13054 _2doi
040			_aNLM _beng _cNLM
100	1		_aTerano, Chikako
245	0	0	_aPractical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients. _h[electronic resource]
260			_bNephrology (Carlton, Vic.) _cJun 2018
300			_a539-545 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article
650	0	4	_aAge Factors
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAtypical Hemolytic Uremic Syndrome _xdiagnosis
650	0	4	_aChild, Preschool
650	0	4	_aComplement Inactivating Agents _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Eruptions _xetiology
650	0	4	_aElectronic Health Records
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aInfant
650	0	4	_aMale
650	0	4	_aMeningococcal Infections _xchemically induced
650	0	4	_aOpportunistic Infections _xchemically induced
650	0	4	_aRemission Induction
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTokyo
650	0	4	_aTreatment Outcome
700	1		_aIshikura, Kenji
700	1		_aHamada, Riku
700	1		_aYoshida, Yasuhiro
700	1		_aKubota, Wataru
700	1		_aOkuda, Yusuke
700	1		_aShinozuka, Shunsuke
700	1		_aHarada, Ryoko
700	1		_aIyoda, Sunao
700	1		_aFujimura, Yoshihiro
700	1		_aHamasaki, Yuko
700	1		_aHataya, Hiroshi
700	1		_aHonda, Masataka
773	0		_tNephrology (Carlton, Vic.) _gvol. 23 _gno. 6 _gp. 539-545
856	4	0	_uhttps://doi.org/10.1111/nep.13054 _zAvailable from publisher's website
999			_c27059958 _d27059958